» Articles » PMID: 27515577

Viruses Are Frequently Present As the Infecting Agent in Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Presenting to Hospital

Overview
Journal Intern Med J
Specialty General Medicine
Date 2016 Aug 13
PMID 27515577
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Viral causes of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are well recognised but only recently have rapid tests become available.

Aims: To identify respiratory viruses in the general population and those associated with hospitalisation in AECOPD using polymerase chain reaction (PCR) on nasopharyngeal aspirate (NPA), and the relationship between symptoms, viral detection and inflammatory markers.

Methods: A review of viruses detected in the general population in a health district between August 2014 and July 2015, using multiplex PCR for viruses from NPA samples. In addition, a single hospital, retrospective audit of patients admitted with suspected AECOPD was conducted.

Results: Of the 8811 NPA tested, 5599 (64%) were positive for at least one virus and 2069 of these were obtained from adults. In adults, the most common viruses identified were Influenza A (31%), Rhinovirus (27%) and respiratory syncytial virus A/B (10%). Most patients with AECOPD (102 of 153) had NPA sent for viral PCR testing and 59 (58%) were positive. The most common viruses identified were Influenza A (31%), Rhinovirus (24%) and respiratory syncytial virus A/B (17%) with co-infecting bacteria cultured in 22 sputum samples. Patients with influenza-like symptoms were more likely to have a positive viral PCR than those without symptoms (P < 0.004). The median C-reactive protein on admission was lower in the virus-infected than uninfected AECOPD (28 vs 60 mg/L, P < 0.026).

Conclusion: The spectrum of viruses detected in patients with AECOPD is similar to that of the general population. Viruses are more likely to be identified in patients with AECOPD who present with influenza-like symptoms and a low C-reactive protein.

Citing Articles

Clinical Characteristics and Outcomes of Hospitalized AECOPDs Secondary to SARS-CoV-2 versus Other Respiratory Viruses.

Chhor L, Saggese S, Hamilton G, MacDonald M Int J Chron Obstruct Pulmon Dis. 2024; 19:2421-2430.

PMID: 39559372 PMC: 11572465. DOI: 10.2147/COPD.S479968.


Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review.

Qian Y, Cai C, Sun M, Lv D, Zhao Y Int J Chron Obstruct Pulmon Dis. 2023; 18:2707-2723.

PMID: 38034468 PMC: 10683659. DOI: 10.2147/COPD.S433183.


Coinfection with influenza virus and non-typeable aggregates inflammatory lung injury and alters gut microbiota in COPD mice.

Wu X, Li R, Lin Z, Xiao C, Liu B, Mai K Front Microbiol. 2023; 14:1137369.

PMID: 37065141 PMC: 10098174. DOI: 10.3389/fmicb.2023.1137369.


COPD Exacerbation-Related Pathogens and Previous COPD Treatment.

Sim Y, Lee J, Lee E, Choi J, Lee C, An T J Clin Med. 2023; 12(1).

PMID: 36614912 PMC: 9821136. DOI: 10.3390/jcm12010111.


Human airway and lung microbiome at the crossroad of health and disease (Review).

Raudoniute J, Bironaite D, Bagdonas E, Kulvinskiene I, Jonaityte B, Danila E Exp Ther Med. 2022; 25(1):18.

PMID: 36561630 PMC: 9748710. DOI: 10.3892/etm.2022.11718.


References
1.
Jamieson A, Yu S, Annicelli C, Medzhitov R . Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe. 2010; 7(2):103-14. PMC: 2836270. DOI: 10.1016/j.chom.2010.01.010. View

2.
Dalton C, Carlson S, McCallum L, Butler M, Fejsa J, Elvidge E . Flutracking weekly online community survey of influenza-like illness: 2013 and 2014. Commun Dis Intell Q Rep. 2015; 39(3):E361-8. View

3.
Seemungal T, Bhowmik A, Moric I, SANDERSON G, Message S, MacCallum P . Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164(9):1618-23. DOI: 10.1164/ajrccm.164.9.2105011. View

4.
Clark T, Medina M, Batham S, Curran M, Parmar S, Nicholson K . C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD. Eur Respir J. 2014; 45(1):76-86. DOI: 10.1183/09031936.00092214. View

5.
Wilkinson T, Hurst J, Perera W, Wilks M, Donaldson G, Wedzicha J . Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest. 2006; 129(2):317-324. PMC: 7094441. DOI: 10.1378/chest.129.2.317. View